Free Trial

Eli Lilly and Company (LLY) Earnings Date, Estimates & Call Transcripts

Eli Lilly and Company logo
$948.01 -26.95 (-2.76%)
Closing price 05/8/2026 03:59 PM Eastern
Extended Trading
$950.10 +2.09 (+0.22%)
As of 05/8/2026 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Eli Lilly and Company Earnings Summary

Eli Lilly and Company issued Q1 2026 earnings on April 30, 2026, reporting an EPS of $8.55, which beat the consensus estimate of $6.97 by $1.58. Quarterly revenue rose 55.5% year-over-year to $19.80 billion, above analyst estimates of $17.82 billion. With a trailing EPS of $28.15 and a P/E Ratio of 33.68, Eli Lilly and Company's earnings are expected to grow 23.43% next year, from $35.68 to $44.04 per share.

Latest Q1
Earnings Date
Apr. 30Estimated
Consensus EPS
(Apr. 30)
$6.97
Actual EPS
(Apr. 30)
$8.55 Beat By $1.58
Actual Revenue
(Apr. 30)
$19.80B

Q1 2026 Earnings Resources

Get Eli Lilly and Company Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Eli Lilly and Company and other key companies, straight to your inbox.

Sign Up
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Estimated and Actual Earnings Data

LLY Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

LLY Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Eli Lilly and Company Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateRevenue EstimateCompany EPS GuidanceCompany Revenue Guidance
Q1 20261$6.61$6.61$6.61
Q2 20261$7.94$7.94$7.94
Q3 20261$8.84$8.84$8.84
Q4 20261$8.34$8.34$8.34
FY 2026 4 $31.73 $31.73 $31.73
Q1 20271$9.46$9.46$9.46
Q2 20271$9.91$9.91$9.91
Q3 20271$11.13$11.13$11.13

Eli Lilly and Company Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
4/30/2026Q1 2026$6.97$8.55+$1.58$8.26$17.82B$19.80B
2/4/2026Q4 2025$7.48$7.54+$0.06$7.39$17.85B$19.29B
10/30/2025Q3 2025$6.42$7.02+$0.60$6.21$16.09B$17.60B
8/7/2025Q2 2025$5.59$6.31+$0.72$6.29$14.40B$15.56B
5/1/2025Q1 2025$4.64$3.34 -$1.30$3.06$12.77B$12.73B
2/6/2025Q4 2024$5.45$5.32 -$0.13$4.88$13.42B$13.53B
10/30/2024Q3 2024$1.52$1.18 -$0.34$1.29$12.09B$11.44B
8/8/2024Q2 2024$2.64$3.92+$1.28$4.56$9.83B$11.30B

Data powered by Fiscal.ai.

Eli Lilly and Company Earnings - Frequently Asked Questions

Eli Lilly and Company (NYSE:LLY) last announced its quarterly earning data on Thursday, April 30, 2026. Learn more on LLY's earnings history.

Eli Lilly and Company updated its FY 2026 earnings guidance on Thursday, April, 30th. The company provided earnings per share guidance of 35.500-37.000 for the period, compared to the consensus estimate of 34.390. The company issued revenue guidance of $82.0 billion-$85.0 billion, compared to the consensus revenue estimate of $81.9 billion.

In the previous quarter, Eli Lilly and Company (NYSE:LLY) reported $8.55 earnings per share (EPS) to beat the analysts' consensus estimate of $6.97 by $1.58. Learn more on analysts' earnings estimate vs. LLY's actual earnings.

The conference call for Eli Lilly and Company's latest earnings report can be listened to online.
Listen to Conference Call

The conference call transcript for Eli Lilly and Company's latest earnings report can be read online.
Read Transcript

Eli Lilly and Company's earnings report can be found in their filing with the SEC.
View SEC filing

Eli Lilly and Company (NYSE:LLY) has a recorded annual revenue of $65.18 billion.

Eli Lilly and Company (NYSE:LLY) has a recorded net income of $20.64 billion. LLY has generated $28.15 earnings per share over the last four quarters.

Eli Lilly and Company (NYSE:LLY) has a trailing price-to-earnings ratio of 33.68 and a forward price-to-earnings ratio of 26.57. The price/earnings-to-growth ratio is 1.07.

Eli Lilly and Company's earnings are expected to grow from $35.68 per share to $44.04 per share in the next year, which is a 23.43% increase.


This page (NYSE:LLY) was last updated on 5/9/2026 by MarketBeat.com Staff.
From Our Partners